GALT

NASDAQ · Biotechnology

Galectin Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.44

-0.09 (-2.55%)

As of Aug 15, 2:10 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +276.7% upside

Low Target $9.51

Average Target $12.96

High Target $17.52

Current Price $3.44

Current
$3.44

Target
$12.96

$9.51 $12.96 avg $17.52

Scenario Analysis

Bear Case

$9.51

176.5%

Low target

Base Case

$12.96

+276.7%

Avg target

Bull Case

$17.52

+409.3%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.13

-51.8% from high

52-Week Low

$2.03

+69.9% from low

Target vs 52W High

$12.96

+81.8% vs high

Next Earnings Report

Aug 17, 2026

tomorrow

EPS Est: $-0.09

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%